EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of aggressive MS using immunoablative treatment with autologous stem cell rescue One year clinical and laboratory follow-up of the first six treated patients



Treatment of aggressive MS using immunoablative treatment with autologous stem cell rescue One year clinical and laboratory follow-up of the first six treated patients



Neurology 60(5 Supplement 1): A85, March 11




(PDF 0-2 workdays service: $29.90)

Accession: 035980887

Download citation: RISBibTeXText



Related references

Immunoablative therapy with autologous stem cell support in the treatment of 25 patients with poor risk multiple sclerosis. Blood 102(11): 986a, November 16, 2003

Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient. Vojnosanitetski Pregled 73(5): 504-508, 2016

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue. Journal of Clinical Oncology 16(10): 3270-3278, 1998

Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis. Transplantation Proceedings 33(3): 2179-2181, 2001

Long-term follow up on patients with Hodgkin lymphoma treated with high-dose BCNU, etoposide, Ara-C, cyclophosphamide and autologous hemopoietic stem cell rescue. Blood 98(11 Part 2): 392b, November 16, 2001

Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. CytoTherapy 11(1): 18-25, 2008

Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation. Zhonghua Xue Ye Xue Za Zhi 36(6): 455-459, 2016

Autologous stem cell transplantation in severe treatment-resistant Crohn's disease: long-term follow-up of UK patients treated on compassionate basis. Qjm 107(11): 871-877, 2015

Two-step immunoablative treatment with autologous peripheral blood CD34+ cell transplantation in an 8-year-old boy with autoimmune haemolytic anaemia. British Journal of Haematology 110(4): 900-902, September, 2000

Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. CytoTherapy 10(6): 565-574, 2008

CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 88(3): 306-314, 2003

Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation. Pediatric Blood & Cancer 60(12): 2018-2024, 2013

High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Pediatric Blood & Cancer 42(3): 261-267, 2004

Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE(R) STn-KLH cancer vaccine. Bone Marrow Transplantation 25(12): 1233-1241, 2000